Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China

10Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Background: Currently, available data regarding previous cervical cytology and high-risk human papillomavirus (hrHPV) test results to detect invasive cervical cancer are limited and controversial in China. Therefore, this retrospective study in a population of Chinese women with invasive cervical carcinoma aimed to gain further insight into the roles of cytology and hrHPV testing in cervical cancer screening. Methods: A total of 1214 cases with a histological diagnosis of invasive cervical cancer were retrieved from the Pathology Database of Jinan KingMed Diagnostics (JKD) over a 5-year period. Previous cytology and hrHPV test results of 469 patients carried out within the year before cancer diagnosis were documented. Results: A higher percentage of patients who had undergone prior screening had micro-invasive cervical carcinoma than patients who had no prior screening (25.4% vs. 12.1%, P < 0.001). Of the 469 patients with available prior screening results, 170 had cytology alone, 161 had hrHPV testing alone, and 138 had both cytology and hrHPV testing. There was a significantly lower percentage of hrHPV-positive cases with adenocarcinoma than with squamous cell carcinoma (77.8% vs. 96.4%, P = 0.001). The hrHPV test showed a significantly higher sensitivity than cytology alone (94.4% vs. 85.3%, P = 0.006). The overall sensitivity of the combination of cytology and hrHPV testing (98.6%) was much higher than that of cytology alone (P < 0.001) but only marginally higher than that of hrHPV testing alone (P = 0.058). Conclusions: The results revealed that prior cervical screening can detect a significantly larger number of micro-invasive cervical cancers. The hrHPV test can provide a more sensitive and efficient strategy than cytology alone. As the addition of cytology to hrHPV testing can only marginally increase the efficiency of the hrHPV test, hrHPV testing should be used as the primary screening approach, especially in the low-resource settings of China.

Figures

  • Table 1. Cervical cancer histological subtypes in the current study.
  • Table 2. Results of prior cytology alone according to the cytological preparation.
  • Table 3. Results of prior cytology alone performed within the year prior to the histological diagnosis of invasive cervical cancer.
  • Table 4. Results of prior HPV testing alone within the year prior to the histological diagnosis of invasive cervical cancer.
  • Table 5. Results of the combination of cytology and hrHPV testing within the year prior to the histological diagnosis of invasive cervical cancer.
  • Table 6. Comparison of the results of cytology, hrHPV testing, and their combination within the year prior to the histological diagnosis of invasive cervical cancer.

References Powered by Scopus

Human papillomavirus and cervical cancer

2318Citations
N/AReaders
Get full text

Efficacy of HPV-based screening for prevention of invasive cervical cancer: Follow-up of four European randomised controlled trials

1400Citations
N/AReaders
Get full text

Human papillomavirus and cervical cancer

905Citations
N/AReaders
Get full text

Cited by Powered by Scopus

HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong’s largest independent pathology laboratory

58Citations
N/AReaders
Get full text

DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan

32Citations
N/AReaders
Get full text

Low Necroptosis Process Predicts Poor Treatment Outcome of Human Papillomavirus Positive Cervical Cancers by Decreasing Tumor-Associated Macrophages M1 Polarization

20Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zhang, L., Xie, F., Wang, X., Peng, D., Bi, C., Jiang, L., … Qi, D. (2017). Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China. PLoS ONE, 12(6). https://doi.org/10.1371/journal.pone.0180618

Readers over time

‘17‘18‘19‘20‘21‘23‘2401234

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

67%

Researcher 2

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

57%

Social Sciences 1

14%

Economics, Econometrics and Finance 1

14%

Immunology and Microbiology 1

14%

Save time finding and organizing research with Mendeley

Sign up for free
0